Oculis Holding AG
OCSAW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001953530
No open-market purchases or sales by Oculis Holding AG insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $1.16M in total; no superinvestor holds it.
Other share classesOCS
Q2 2024 vs. Q1 2024
How the institutions holding Oculis Holding AG changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 24 | 24 | 0 |
| Shares | 603.6K | 585.0K | −18.7K (−3.1%) |
| Value | $1.45M | $1.08M | −$362.4K (−25.0%) |
New holders (1)
Institutions that held Oculis Holding AG at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Group AG | 9,652 | $17.9K | 0.00% |
Sold out (1)
Institutions that held Oculis Holding AG at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Tenor Capital Management Co., L.P. | 33,333 | $73.3K |